Company news
Nexgel, Inc (NASDAQ:NXGL) news
Nexgel, Inc news releases on 6ix. Latest, May 9, 2024: NEXGEL to Report First Quarter 2024 Financial Results on May 13th
Press releases — page 2
NEXGEL to Report First Quarter 2024 Financial Results on May 13th
May 8, 2024
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
March 31, 2024
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
March 26, 2024
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
March 20, 2024
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders
February 20, 2024
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
January 8, 2024
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
December 10, 2023
NEXGEL Acquires Kenkoderm Psoriasis Skincare Line
December 4, 2023
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
November 12, 2023
NEXGEL to Report Third Quarter 2023 Financial Results on November 13th
November 1, 2023
NEXGEL Secures Supply Agreement with AbbVie
October 29, 2023
NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year
August 13, 2023
NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America
July 18, 2023
NEXGEL Reports First Quarter 2023 Financial Results
May 14, 2023
NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results
March 26, 2023
NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th
March 14, 2023
NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business
March 1, 2023
NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee
January 16, 2023
NEXGEL Announces Share Repurchase Program
December 6, 2022
NEXGEL Reports Third Quarter 2022 Financial Results
November 7, 2022
NEXGEL to Report Third Quarter 2022 Financial Results on November 8th
November 1, 2022
NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board
September 28, 2022
NEXGEL Reports Second Quarter 2022 Financial Results
August 9, 2022
NEXGEL Reports First Quarter 2022 Financial Results
May 11, 2022
NEXGEL to Report its First Quarter 2022 Financial and Operating Results on May 12, 2022
May 8, 2022
NEXGEL Reports Fourth Quarter and Full Year 2021 Financial Results
March 20, 2022
NEXGEL Announces Launch of MEDAGEL Bug Bite Relief Patch
February 14, 2022
NEXGEL Announces the Launch of MEDAGEL ClearComfort Hydrogel Patch
January 11, 2022
NexGel, Inc. Announces Closing of $14.2 Million Initial Public Offering
December 26, 2021
NexGel, Inc. Announces Listing on Nasdaq and Pricing of $14.2 Million Initial Public Offering
December 20, 2021